Trials / Completed
CompletedNCT05296252
Attention and Achievement: A Mind Wandering Investigation
Attention and Achievement (A Subproject Affiliated With the Texas Center for Learning Disabilities or TCLD)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- University of Houston · Academic / Other
- Sex
- All
- Age
- 11 Years – 15 Years
- Healthy volunteers
- Accepted
Summary
This study assesses the impact of mind-wandering on reading and math.
Detailed description
This study assesses the impact of mind-wandering on reading and math. Specifically 120 middle school student participants will receive descriptive measures (of achievement, attention and related factors including mind-wandering), and will receive a brief (\~30 min) lesson in reading and math (order counterbalanced). Participants will receive a brief pre-test, the lesson, and then a post-test on the reading and math outcomes. 75% of the participants will receive a brief manipulation that sets up the influence of mind-wandering, as well as redirects when probe-caught mind-wandering occurs. The remaining participants will receive only redirects, and only randomly. Among participants to receive the mind-wandering manipulation, an equal number will receive this only for reading, only for math, and for both reading and math.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | mind-wandering intervention | Participants in this condition receive a brief introduction to the potential impact of mind-wandering (before learning, proactive), and are redirected to lesson if "probe-caught" mind-wandering are endorsed (during learning, reactive) |
| BEHAVIORAL | mind-wandering comparison | Participants in this condition receive no introduction, and only redirection, and the redirection is random, not in reaction to mind-wandering |
Timeline
- Start date
- 2022-05-11
- Primary completion
- 2022-06-15
- Completion
- 2022-06-15
- First posted
- 2022-03-25
- Last updated
- 2023-05-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05296252. Inclusion in this directory is not an endorsement.